US equities |
NVDA $221.30 ▼-3.16% MU $914.13 ▼-4.10% AAPL $342.96 ▲+0.50% AMD $570.82 ▼-5.73% META $737.54 ▼-3.27% MSFT $533.69 ▼-1.80% TSLA $367.16 ▼-2.15% INTC $98.12 ▼-4.56%
FinancialContent

Latest News about melanoma

Recent news which mentions melanoma

Cancer 2023: What’s Happening in the Combat Zone?
Tags Genentech gemcitabane Mirati Therapeutics (MRTX)
From Stock Gumshoe
'Spot Detective' – Check your spots this summer
Tags Medical Research Basal Cell Carcinoma
From PRLog
Intermountain Healthcare Experts Give the Best Ways to Keep Your Child’s Skin Safe
Tags squamous cell carcinoma Healthcare Intermountain Healthcare
From PRUnderground
Protecting You and Your Family from Skin Cancer This Summer
Tags Intermountain Healthcare skin cancer Healthcare
From PRUnderground
Iovance Outlines Frontline Melanoma Strategy For Lifileucel / Pembrolizumab Combo Therapy
Tickers IOVA MRK
Tags melanoma News Briefs
From Benzinga
Merck's Keytruda Shows Improved Metastasis-Free Survival In Melanoma Patients
Tickers MRK
Tags News Phase 3 Trial Market News
From Benzinga
Alkermes Educates on the Challenges of Mucosal Melanoma
Tickers ALKS
Tags melanoma Health & Healthcare Alkermes
From 3BL Media: Corporate Social Responsibility, Energy and Health News
French Regulatory Authority Gives Green Signal To Phio Pharma's Melanoma Trial
Tickers PHIO
Tags Biotech Movers Benzinga
From Benzinga
Merck's Keytruda Wins Eighth FDA Approval Of 2021, This Time For Adjuvant, Pediatric Melanoma Settings
Tickers MRK
Tags melanoma News Briefs
From Benzinga
New Data Reaffirms Merck's Keytruda In Extending Survival In Melanoma Patients
Tickers BMY MRK
Tags Phase 3 Trial News Market News
From Benzinga
See Why Sonnet BioTherapeutics Stock Is Skyrocketing In Premarket Tuesday
Tickers SONN
Tags Briefs Health Care Movers
From Benzinga
Alkermes Receives FDA Fast Track Status For Mucosal Melanoma Immunotherapy
Tickers ALKS
Tags General Biotech Benzinga
From Benzinga